Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
11/2007
11/29/2007US20070275083 ameliorating chronic renal insufficiency, hypertension, atherosclerosis, and chronic congestive heart failure
11/29/2007US20070275014 Influenza antigens, vaccine compositions, and related methods
11/29/2007US20070275012 Pharmaceutical Compositions for Therapeutic Use
11/29/2007US20070275004 Group b streptococcus antigens
11/29/2007US20070274998 Novel Bispecific Molecules For Use In Therapy And Diagnosis
11/29/2007US20070274997 Compositions and Methods for Herpes Simplex Prophylaxis and Treatment
11/29/2007US20070274995 Cardiotrophin-1 compositions and methods for the treatment of tumor
11/29/2007US20070274988 Kiaa0779, Splice Variants Thereof, and Methods of Their Use
11/29/2007US20070274973 Method of controlling fungal pathogens, and agents useful for same
11/29/2007US20070274970 Stem Cells
11/29/2007US20070274950 Interferon-alpha polypeptides and conjugates
11/29/2007US20070272998 Semiconductor Device
11/29/2007CA2653104A1 Preparation and uses of gene sequences encoding chimerical glycosyltransferases with optimized glycosylation activity
11/29/2007CA2652578A1 Erythropoietin compositions
11/29/2007CA2652538A1 Fusion proteins, uses thereof and processes for producing same
11/28/2007EP1860190A2 Neutrokine-alpha and neutrokine-alpha splice variants
11/28/2007EP1860189A1 Human gene
11/28/2007EP1860188A2 Human cytokine receptor
11/28/2007EP1860187A1 Apo-2 receptor
11/28/2007EP1860186A2 Method for distinguishing mesenchymal stem cells using different markers
11/28/2007EP1860184A1 Novel polypeptide, polynucleotide encoding the polypeptide and use the polypeptide and polynucleotide
11/28/2007EP1860182A1 Method of regenerating elastic fiber with the use of dance or factor enhancing the expression thereof
11/28/2007EP1860120A1 Method for improving antibody
11/28/2007EP1860117A2 Anti-bacterial vaccine compositions
11/28/2007EP1859057A2 Improved halohydrin dehalogenases and related polynucleotides
11/28/2007EP1859047A1 Cyanophycin production from nitrogen-containing chemicals obtained from biomass
11/28/2007EP1859046A1 Expression vector for animal cell comprising at least one copy of mar dna sequences at the 3'terminal of transcription termination region of a gene and method for the expression of foreign gene using the vector
11/28/2007EP1859043A1 Phage-derived vectors and methods for protein expression
11/28/2007EP1858926A1 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
11/28/2007EP1858911A2 Macromolecules comprising a thioether cross-link
11/28/2007EP1858546A2 Modified transferrin fusion proteins
11/28/2007EP1601689B1 Purification process for bacterial cytolysin
11/28/2007EP1115863B1 Ucp4
11/28/2007EP0977844B1 Mammal neuronal acid sensing cationic channel, cloning and applications thereof
11/28/2007EP0910387B1 Apoptosis associated protein bbk
11/28/2007CN101080496A Methods for antibody engineering
11/28/2007CN101080418A Tripeptide and tetrapeptide sulfones
11/28/2007CN101080239A Stabilized HBc chimer particles as therapeutic vaccine for chronic hepatitis
11/28/2007CN101077500A Processing method for biological pharmacy waste residue
11/28/2007CN100351386C Production of valuable compound by using chemically defined culture medium and adopting industrial scal fermentation process
11/28/2007CN100351383C Methods for producing polypeptides in respiratory-deficient cells
11/28/2007CN100351377C Gene of expressing regeneration enhancement factor of recombined human liver in full length, and method for preparing regeneration enhancement factor of recombined human liver in full length, and usag
11/27/2007US7301016 Comprises nucleotide sequences coding enzymatic polypeptide for diagnosing and treating cell proliferative disorders; animal models
11/27/2007US7301008 PRO7174 polypeptides
11/27/2007US7301007 PRO4340 polypeptides
11/27/2007US7300786 Using transgenic gramnegative bacteria as bioreactor for fermentation of histidine to be used in medicine, cosmetics and animal feeds
11/27/2007US7300774 Injected locally as a vaccine adjuvant or tumor immunotherapy agent to prevent them from diffusing away
11/27/2007US7300773 Production of TNFR-Ig
11/27/2007US7300772 Bone morphogenic protein for use in the treatment of bone disorders; for use as wound healing agent
11/27/2007US7300762 Introducing into a cell a nucleic acid molecule comprising a nucleotide sequence encoding a modified Green Fluorescent Protein (GFP) fused to a nucleotide sequence encoding a protein of interest; culturing; determining the cellular and/or extracellular localisation of protein by detecting fluorescence
11/27/2007US7300753 immunoglobulin which binds phosphorylated ubiquitin fusion degradation protein 1 (UFD1) for use in diagnosis, prevention and treatment of cardiovascular and cell proliferative disorders
11/27/2007US7300678 Using white almond paste; prevent wrinkling of skins
11/27/2007US7300656 Treatment of inflammatory bowel disease with IFN-gamma inhibitors
11/27/2007US7300652 Contacting cell expressing kidney injury-molecule-1 (KIM-1) cell surface polypeptide with an effective amount of an isolated antibody or antigen-binding-fragment thereof that binds to the extracellular domain of the human KIM-1 polypeptide
11/27/2007CA2208751C Oil body proteins as carriers of high value proteins
11/27/2007CA1341562C Gene coded for interleukin-2 polypeptide, recombinant dna carrying the said gene, a living cell line possessing the recombinant dna, and method for producing interleukin-2 using the said cell
11/22/2007WO2007133993A2 System and method for reducing driving risk with foresight
11/22/2007WO2007133781A2 Furanone-initiated polymers
11/22/2007WO2007133595A2 Integrated vacuum absorption steam cycle gas separation
11/22/2007WO2007133373A2 TNF-α VACCINE FOR TREATING DISEASE CONDITIONS MEDIATED BY PATHOLOGICAL TNF-α
11/22/2007WO2007132949A1 High secretion production method of protein
11/22/2007WO2007132917A1 Phage-displaying single-chain antibody capable of recognizing non-reduced mannose residue
11/22/2007WO2007131424A1 Method for preparing low molecular weight proteoglycan and collagen compositions, its products and uses
11/22/2007WO2007053558A3 Vancomycin formulations having reduced amount of histamine
11/22/2007WO2007027805A3 Method for generating anti-variable region monoclonal antibodies
11/22/2007WO2007022009A3 Materials and methods to increase peptide chain expression
11/22/2007WO2006092669A3 Methods of detecting a phenotype of a polymorphic protein
11/22/2007WO2006044352A3 Canine cholecystokinin 1 receptor materials and their use
11/22/2007WO2005067478A3 Recombinant icosahedral virus like particle production in pseudomonads
11/22/2007WO2005035716A3 Nucleic acid molecules encoding novel human low-voltage activated calcium channel proteins, designated - alpha 1i-1 and alpha 1i-2, encoded proteins and methods of use thereof
11/22/2007WO2005012547A3 Multimeric oxidoreductases
11/22/2007WO2003006672A3 Antimicrobial nucleic acid antibodies, and materials and methods for making and using same
11/22/2007WO2000018212A8 Platelet-derived growth factor c, dna coding therefor, and uses thereof
11/22/2007US20070271624 Gene Encoding an Enzyme for Catalyzing Biosynthesis of Lignan, and Use Thereof
11/22/2007US20070270575 Protein showing enhanced expression in cancer cells
11/22/2007US20070270506 Novel human kinases and polynucleotides encoding the same, and uses thereof
11/22/2007US20070270361 Sars Nucleic Acids, Proteins, Vaccines, and Uses Thereof
11/22/2007US20070270334 Polypeptide-dimers for use in treatment and prevention of infection, bone, blood, eating, tumor, autoimmune and inflammatory disorders
11/22/2007US20070269879 Methods of Refolding Mammalian Glycosyltranferases
11/22/2007US20070269868 Culture method for obtaining a clonal population of antigen-specific B cells
11/22/2007US20070269867 Protein markers associated with bone marrow stem cell differentiation into early progenitor dendritic cells
11/22/2007US20070269866 Methods and compositions for producing vitamin K dependent proteins
11/22/2007US20070269865 Recombinant fragments of the human acetylcholine receptor and their use for treatment of myasthenia gravis
11/22/2007US20070269864 Designer proton-channel transgenic algae for photobiological hydrogen production
11/22/2007US20070269863 Process for the production of preformed conjugates of albumin and a therapeutic agent
11/22/2007US20070269862 Installation of genomes or partial genomes into cells or cell-like systems
11/22/2007US20070269861 Soluble recombinant botulinum toxin proteins
11/22/2007US20070269859 An isolated polynucleotide encoding a polypeptide having at least 90% sequence identity to SEQ ID NO:7 and having lecithin:cholesterolacyltransferase-like activity to alter sterol composition and oil production in plants and host cells; improved fatty acid, carotenoid, sterol and tocopherol; health
11/22/2007US20070269858 Combinatorial Biology
11/22/2007US20070269856 Viral Purification Methods
11/22/2007US20070269838 Method for Whole Surrounding Surface Display of Target Proteins Using Bacterial Exoporium
11/22/2007US20070269462 Novel exoenzyme toxin of Aeromonas salmonicida, and uses therefor
11/22/2007US20070269445 Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV), proteins encoded by the polynucleic acids, vaccines based on the proteins and/or polynucleic acids, a method of protecting a pig from a PRRSV and a method of detecting a PRRSV
11/22/2007US20070269437 Pro-Inflammatory and Anti-Inflammatory Antibodies Against the Heparin-Binding Protein (Hbp)
11/22/2007US20070269436 Method of Antibody Production
11/22/2007US20070269435 Modified fusion protein comprising an anti-EGFR immunoglobulin moiety and a cytokine polypeptide moiety linked together
11/22/2007US20070269425 Anti-Idiotype Antibodies of the Human Monoclonal Antibody Sc-1, and Their Production and Use
11/22/2007US20070269408 GENES OF IL-12p40 SUBUNIT MUTATED FOR IMPROVING THE ACTIVITY OF IL-12 AND USE THEREOF FOR DNA VACCINE ADJUVANT
11/22/2007US20070269394 Peptide-based body surface coloring reagents
11/22/2007US20070269372 monoclonal antibodies or fragment thereof which binds a cell surface glycoprotein antigen located on the surface of human multiple myeloma tumor cells; for therapeutic, screening, diagnostic and cell purification purposes
1 ... 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 ... 1125